Sleep therapy is the largest use, and glucose monitoring is second with 19.5 million connections.
Why this market is moving now
- Connected home monitoring devices are forecast to grow 11.5% a year to 159.7 million by 2030.
- Glucose monitoring reached 19.5 million connections in 2025, driven by continuous glucose monitors and connected insulin delivery.
- Abbott's continuous glucose monitor sales grew 15.0% in the fourth quarter of 2025.
Key figures
Global figures for this market, with the year each one describes. Use Cite to copy a reference to this page.
| Figure | Value | Year | Cite |
|---|---|---|---|
| There were 92.7 million connected home medical monitoring devices in use in care programs worldwide in 2025. | 92.7 million devices | 2025 | |
| The number of connected home medical monitoring devices worldwide is forecast to grow 11.5% a year to 159.7 million by 2030. | 159.7 million devices (forecast) | 2030 | |
| Glucose monitoring and insulin delivery was the second-largest home monitoring segment worldwide after sleep therapy, with 19.5 million connections at the end of 2025. | 19.5 million connections | 2025 | |
| ResMed had more than 37 million patients on its AirView cloud platform and more than 12.5 million on its myAir app in 2026. | 37 million patients | 2026 | |
| ResMed's revenue rose 10% to $5.7 billion in its fiscal year to June 2026. | 5.7 USD billion | 2026 | |
| Abbott's Diabetes Care business, which sells continuous glucose monitors, had worldwide sales of $7,998 million in 2025, up 17.5%. | 7,998 USD million | 2025 | |
| Abbott's continuous glucose monitor sales were $2.0 billion in the fourth quarter of 2025, up 15.0%. | 2.0 USD billion | 2025 | |
| Dexcom's worldwide revenue grew 16% to $4.662 billion in 2025. | 4.662 USD billion | 2025 |
Calculated figures (shares, changes and prices per kilogram) are plain arithmetic on the reported values. Read how we work.
Companies to watch
ResMed
Sleep and breathing device maker with more than 37 million patients on its AirView cloud platform.
Abbott
Its Diabetes Care business, which sells continuous glucose monitors, had sales of $7,998 million in 2025.
Dexcom
Continuous glucose monitor maker with 2025 revenue of $4.662 billion.
What the full report covers
- 01Executive summary
The answer in one page: size, direction and what moves it - 02Market definition and scope
What is in and out of the global market - 03Global market size, 2021 to 2025
Historical series and growth rates - 04Countries and regions
Demand, supply and trade by country and region - 05Outlook to 2031
Base, low and high scenarios with stated assumptions - 06Rules, policy and deadlines
Regulation and programmes that change demand - 07Drivers and barriers
What accelerates or slows adoption, by customer segment - 08Prices, costs and margins
Unit economics where public data allows - 09Competitive landscape
8 to 12 company profiles with recent moves - 10Opportunities and risks
For new entrants, suppliers and investors - 11Method and assumptions
How every figure was built
Included with the full report
- PDF report, 40 to 60 pages
- Excel data pack
- Ready-to-use charts
- Method note and assumptions
- Written to order in 5 working days
Frequently asked questions
How big is the global remote patient monitoring market?
There were 92.7 million connected home medical monitoring devices in use in care programs worldwide in 2025. Personal fitness and health trackers are not counted.
How fast is remote patient monitoring growing?
The number of connected home monitoring devices is forecast to grow 11.5% a year to 159.7 million by 2030.
What are the main uses of remote patient monitoring?
Sleep therapy is the largest segment. Glucose monitoring and insulin delivery is second, with 19.5 million connections at the end of 2025.
Who are the largest remote patient monitoring companies?
ResMed has more than 37 million patients on its AirView platform and had revenue of $5.7 billion in fiscal 2026. Abbott's Diabetes Care sales were $7,998 million in 2025, and Dexcom's revenue was $4.662 billion.
How big are continuous glucose monitor sales?
Abbott sold $2.0 billion of continuous glucose monitors in the fourth quarter of 2025, up 15.0%. Dexcom's full year 2025 revenue was $4.662 billion.
Free sample
Get a free sample of this report
We send the table of contents, two sample chapters and the method note, usually within one working day. It is free to ask.
- Full table of contents
- Two sample chapters
- Method note and data outline